ISMPP Highlights
ISMPP Members Offered Discount on EMWA Membership
The European Medical Writers Association (EMWA) is offering ISMPP members a 10% discount on EMWA membership. EMWA represents, supports, and trains medical communication professionals. It has more than 1,000 members in Europe and beyond. Members work in all sectors of medical writing…
Record-Setting Attendance at 2017 European Meeting of ISMPP
With 254 attendees participating in the European Meeting of ISMPP, January 17-18, 2017, in London, UK, the Society achieved a record-setting attendance for this increasingly popular conference. Building on its theme, The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment, the meeting focused on…
Global Transparency Committee
With the evolving requirements and expectations for the pharmaceutical industry to increase its transparency related to clinical trial data, medical publication practices and financial disclosure, the need exists for ISMPP members to stay apprised of recent developments and current best practices for adoption by their companies. The ISMPP Global Transparency Committee…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Meta-analysis and Mixed Treatment Comparison Analysis – Powerful Tools with Benefits and Challenges
Evidence-based healthcare decision making is gaining global acceptance in both healthcare policy and clinical practice. Randomized controlled trials (RCTs) are the “gold standard” of evidence, but these studies are usually limited to comparison of two treatments, and thus cannot represent the entirety of treatment options or patient populations…
HEOR: Why It Is Changing the World of Medical Publications
Health economics and outcomes research (HEOR) has been the fastest-growing function in the pharmaceutical industry for a decade or more. Medical publication professionals are seeing publication plans increasingly populated by HEOR studies – particularly post-launch. While medical publication professionals are accustomed to working with…
Predatory Journals: Everyone’s Problem
The growing availability and marketing of “predatory journals” – fake or fraudulent journals with questionable or no quality control standards – raise challenges for the scientific community. It can be difficult to distinguish predatory journals from established journals, making it important for researchers, institutions, and medical publication professionals to know about their existence and practices…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Author Says “No COI” Despite Possible COI
You are a publication professional. A non-industry author states on his/her conflict of interest (COI) form that he/she has “no COI” despite your knowledge that he/she is engaged by several companies for consultancy and speaker engagements. What would you do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals